CCM
RMD icon

Coldstream Capital Management’s ResMed RMD Stock Holding History

Coldstream Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4M Buy
10,705
+7,296
+214% +$1.82M 0.03% 250
2025
Q4 		$821K Sell
3,409
-1,251
-27% -$320K 0.01% 521
2025
Q3 		$1.28M Buy
4,660
+881
+23% +$241K 0.02% 403
2025
Q2 		$975K Buy
3,779
+917
+32% +$219K 0.02% 431
2025
Q1 		$641K Sell
2,862
-122
-4% -$28.5K 0.01% 504
2024
Q4 		$682K Sell
2,984
-41
-1% -$9.87K 0.01% 488
2024
Q3 		$736K Buy
3,025
+278
+10% +$62.1K 0.02% 475
2024
Q2 		$526K Buy
2,747
+77
+3% +$15.6K 0.01% 531
2024
Q1 		$529K Sell
2,670
-7
-0.3% -$1.28K 0.01% 532
2023
Q4 		$460K Buy
2,677
+595
+29% +$91.4K 0.01% 539
2023
Q3 		$308K Sell
2,082
-351
-14% -$63.5K 0.01% 592
2023
Q2 		$532K Buy
2,433
+25
+1% +$5.57K 0.02% 428
2023
Q1 		$527K Sell
2,408
-429
-15% -$93.1K 0.02% 425
2022
Q4 		$590K Buy
+2,837
New +$623K 0.02% 378
2022
Q2 		$837K Buy
3,992
+2,829
+243% +$602K 0.03% 260
2022
Q1 		$282K Sell
1,163
-2,394
-67% -$579K 0.01% 595
2021
Q4 		$926K Sell
3,557
-5,737
-62% -$1.49M 0.03% 259
2021
Q3 		$1.59M Buy
9,294
+6,331
+214% +$1.73M 0.08% 127
2021
Q2 		$730K Sell
2,963
-104
-3% -$21.9K 0.03% 227
2021
Q1 		$595K Sell
3,067
-5,662
-65% -$1.14M 0.03% 203
2020
Q4 		$1.85M Sell
8,729
-311
-3% -$62K 0.11% 93
2020
Q3 		$1.55M Sell
9,040
-477
-5% -$88.1K 0.13% 94
2020
Q2 		$1.83M Sell
9,517
-779
-8% -$127K 0.16% 88
2020
Q1 		$1.52M Sell
10,296
-1,804
-15% -$287K 0.17% 88
2019
Q4 		$1.88M Sell
12,100
-184
-1% -$26.5K 0.15% 92
2019
Q3 		$1.66M Sell
12,284
-262
-2% -$34.3K 0.14% 103
2019
Q2 		$1.53M Sell
12,546
-267
-2% -$29.6K 0.13% 102
2019
Q1 		$1.33M Sell
12,813
-302
-2% -$31.2K 0.12% 101
2018
Q4 		$1.49M Buy
13,115
+349
+3% +$37.4K 0.15% 103
2018
Q3 		$1.47M Buy
12,766
+871
+7% +$95.4K 0.13% 100
2018
Q2 		$1.23M Sell
11,895
-26
-0.2% -$2.63K 0.12% 100
2018
Q1 		$1.17M Buy
11,921
+262
+2% +$24.8K 0.13% 99
2017
Q4 		$987K Buy
11,659
+352
+3% +$29.1K 0.11% 113
2017
Q3 		$870K Buy
11,307
+39
+0.3% +$2.98K 0.1% 121
2017
Q2 		$877K Buy
11,268
+877
+8% +$62.7K 0.11% 114
2017
Q1 		$748K Buy
10,391
+710
+7% +$49.1K 0.1% 115
2016
Q4 		$601K Buy
9,681
+2,788
+40% +$171K 0.1% 122
2016
Q3 		$447K Sell
6,893
-6,807
-50% -$453K 0.08% 132
2016
Q2 		$866K Buy
13,700
+7,259
+113% +$428K 0.15% 105
2016
Q1 		$372K Buy
6,441
+943
+17% +$53.4K 0.07% 145
2015
Q4 		$295K Buy
5,498
+1,021
+23% +$57.6K 0.06% 132
2015
Q3 		$228K Buy
+4,477
New +$241K 0.06% 154

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Coldstream Capital Management's RMD Position: Q1 2026 in Review

Coldstream Capital Management increased its ResMed (RMD) stake by 214% in Q1 2026, buying an estimated $1.82M and bringing the position to 10,705 shares worth $2.4M. The position accounts for 0.03% of the portfolio, ranked #250.

Coldstream Capital Management first reported a position in RMD in Q3 2015 and has held it in 42 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Coldstream Capital Management held 10,705 shares of ResMed worth $2.4M as of Q1 2026.
  • Coldstream Capital Management bought 7,296 ResMed shares in Q1 2026, an estimated $1.82M.
  • ResMed made up 0.03% of Coldstream Capital Management's portfolio in Q1 2026, its #250 holding.
  • Coldstream Capital Management first reported a position in ResMed in Q3 2015 and has held it in 42 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.